Authors: de Jong, M Breeman, WAP Bernard, BF Bakker, WH Schaar, M van Gameren, A Bugaj, JE Erion, J Schmidt, M Srinivasan, A Krenning, EP

Citation: M. De Jong et al., [Lu-177-DOTA(0), Tyr(3)]octreotate for somatostatin receptor-targeted radionuclide therapy, INT J CANC, 92(5), 2001, pp. 628-633

Authors: Bernard, BF Krenning, E Breeman, WAP Visser, TJ Bakker, WH Srinivasan, A De Jong, M

Citation: Bf. Bernard et al., Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy, NUCL MED C, 21(11), 2000, pp. 1079-1085

Authors: de Jong, M Breeman, WAP Bernard, BF van Gameren, A de Bruin, E Bakker, WH van der Pluijm, ME Visser, TJ Macke, HR Krenning, EP

Citation: M. De Jong et al., Tumour uptake of the radiolabelled somatostatin analogue [DOTA(0),TYR3]octreotide is dependent on the peptide amount, EUR J NUCL, 26(7), 1999, pp. 693-698

Authors: de Jong, M Bakker, WH Bernard, BF Valkema, R Kwekkeboom, DJ Reubi, JC Srinivasan, A Schmidt, M Krenning, EP

Citation: M. De Jong et al., Preclinical and initial clinical evaluation of In-111-labeled nonsulfated CCK8 analog: A peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy, J NUCL MED, 40(12), 1999, pp. 2081-2087

Authors: Breeman, WAP De Jong, M Bernard, BF Kwekkeboom, DJ Srinivasan, A Van der Pluijm, ME Hofland, LJ Visser, TJ Krenning, EP

Citation: Wap. Breeman et al., Pre-clinical evaluation of [In-111-DTPA-Pro(1), Tyr(4)] bombesin, a new radioligand for bombesin-receptor scintigraphy, INT J CANC, 83(5), 1999, pp. 657-663

Authors: Breeman, WAP Hofland, LJ de Jong, M Bernard, BF Srinivasan, A Kwekkeboom, DJ Visser, TJ Krenning, EP

Citation: Wap. Breeman et al., Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy, INT J CANC, 81(4), 1999, pp. 658-665